About MyLin
MyLin was a Healthcare company based in Chennai (India) founded in 2014. MyLin provides comprehensive marketing solutions for acute and chronic segment pharmaceutical products. It operates on a B2B model. Its Indian entity Mylin Pharmaceuticals Private Limited reported revenue of ₹71.5 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Marketing Services and Acute and Chronic Products. Its competitors include Zevra, Sayre Therapeutics, Supreme Optimization, Andira and Life Science Connect and 3 more; 3 of its 8 listed competitors have raised funding.
Company details
MyLin operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, marketing services, and acute and chronic products. MyLin provides comprehensive marketing solutions for acute and chronic segment pharmaceutical products. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Chennai, India
- SectorsHealthcare
- Website mylin.in
- Legal Name Mylin Pharmaceuticals Private Limited
- Date of Incorporation 28 Oct, 2014
- Jurisdiction Vijayawada, Andhra Pradesh, India
- Annual Revenue₹71.5 Lakh
FY 2020 · -2% YoY
- Net Profit₹1.1 Lakh
FY 2020 · 1% margin
- EBITDA₹9.6 Lakh
FY 2020 · 13% margin
Associated legal entities of MyLin
MyLin operates through Mylin Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mylin Pharmaceuticals Private Limited CIN U24100AP2014PTC095548 | Active | 28 Oct 2014 | Vijayawada, Andhra Pradesh | ₹0.7 Cr | – | 2 | View details |
Board of directors of Mylin Pharmaceuticals Private Limited (MyLin)
Mylin Pharmaceuticals Private Limited is the primary company behind MyLin. The board of Mylin Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sanjoy Das, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjoy Das DIN 07229288 | Director | 03 Sep 2015 | 11 yrs 1 mo | Mylin Pharmaceuticals Private Limited |
| Chittithoti Soma DIN 07229282 | Director | 10 Feb 2018 | 8 yrs 8 mo | Mylin Pharmaceuticals Private Limited |
Financials of MyLin
Figures of Mylin Pharmaceuticals Private Limited, the primary company behind MyLin, for FY 2020. Revenue was ₹71.5 Lakh (-2% year on year). Net profit was ₹1.1 Lakh (1% margin). EBITDA was ₹9.6 Lakh (13% margin). Revenue has grown at a compounded annual rate of +55% over three years.
- ₹71.5 LakhRevenue · FY 2020 · -2% YoY
- ₹1.1 LakhNet profit · 1% margin
- ₹9.6 LakhEBITDA · 13% margin
- ₹1 LakhPaid-up capital
- +55%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Mylin Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for MyLin
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of MyLin
MyLin has 8 listed competitors in our database, 3 of them funded. They include Zevra, Sayre Therapeutics, Supreme Optimization, Andira and Life Science Connect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zevra.com | 2006 | Celebration, United States | – | 45 | Marketing services are provided to biopharma companies. | |
| sayretherapeutics.com | 2015 | Bengaluru, India | $7.9M | 23 | Access to therapies for rare and life-threatening diseases is provided. | |
| supremeopti.com | 2012 | San Juan, Puerto Rico | – | – | Digital marketing services are offered to the life sciences sector. | |
| andira.ca | 2020 | Vancouver, Canada | $1.43M | – | Digital pharmacotherapeutic platform for providers | |
| lifescienceconnect.com | 2009 | Erie, United States | – | – | Marketing and commercialization services for biopharma sector are provided. | |
| woodwardpharma.com | 2015 | Wixom, United States | – | – | Pharmaceutical company that provides outsourced marketing, sales, and commercial services for pharmaceutical companies | |
| ethosh.com | 2012 | Pune, India | $275,084 | 45 | Provider of digital experience and marketing services to health-tech and life-sciences organizations | |
| anpharmaceuticals.com | 2001 | Delhi, India | – | 71 | A pharmaceutical marketing company with a network in Delhi-NCR and UP. |
Detailed competitors of MyLin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as MyLin (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MyLin
MyLin was founded in 2014.
MyLin is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
The primary company behind MyLin, Mylin Pharmaceuticals Private Limited, reported revenue of ₹71.5 Lakh for FY 2020, down 2% year on year.
MyLin operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, marketing services, and acute and chronic products. MyLin provides comprehensive marketing solutions for acute and chronic segment pharmaceutical products. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
MyLin's top competitors include Zevra, Sayre Therapeutics and Ethosh.
MyLin operates through Mylin Pharmaceuticals Private Limited.
The legal entities of MyLin currently have 2 directors, including Chittithoti Soma, Sanjoy Das.